Provided by Tiger Trade Technology Pte. Ltd.

Brookdale Senior Living

14.18
+0.24001.72%
Post-market: 14.15-0.0300-0.21%16:54 EDT
Volume:2.25M
Turnover:32.07M
Market Cap:3.37B
PE:-12.69
High:14.49
Open:14.20
Low:14.10
Close:13.94
52wk High:17.09
52wk Low:4.97
Shares:237.66M
Float Shares:233.91M
Volume Ratio:0.50
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1170
EPS(LYR):-1.1170
ROE:-308.16%
ROA:1.07%
PB:-75.30
PE(LYR):-12.69

Loading ...

Brookdale Senior Living Is Maintained at Overweight by Barclays

Dow Jones
·
Feb 03

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Brookdale Senior Living (BKD)

TIPRANKS
·
Feb 03

Brookdale Senior Living Likely to Benefit from Rising Demand, RBC Says

MT Newswires Live
·
Feb 03

Brookdale Senior Living Is Maintained at Outperform by RBC Capital

Dow Jones
·
Jan 29

Brookdale Senior Living price target raised to $17 from $13 at RBC Capital

TIPRANKS
·
Jan 29

RBC Raises Price Target on Brookdale Senior Living to $17 From $13, Keeps Outperform Rating

MT Newswires Live
·
Jan 29

Bank of America Securities Reaffirms Their Buy Rating on Brookdale Senior Living (BKD)

TIPRANKS
·
Jan 29

Brookdale Senior Living Issues Upbeat 2025 Preliminary Outlook

TIPRANKS
·
Jan 29

Brookdale Senior Living sees 2025 revenue $3.2B, consensus $3.19B

TIPRANKS
·
Jan 29

Brookdale Senior Living sees 2026 adjusted EBITDA $502M-$516M

TIPRANKS
·
Jan 29

Brookdale Senior Living Projects 2025 Revenue of $3.2 Billion

Reuters
·
Jan 29

Brookdale Senior Living Inc Outlook FY26 Revpar Year-Over-Year Growth 8.0% to 9.0%

THOMSON REUTERS
·
Jan 29

Brookdale Senior Living Inc - Projects 2026 Adj Ebitda of $502-$516 Mln

THOMSON REUTERS
·
Jan 29

Brookdale Senior Living Inc - Expects 2025 Revenue of $3.2 Bln

THOMSON REUTERS
·
Jan 29

Brookdale Announces Preliminary Full Year 2025 Results and Introduces Full Year 2026 Annual Guidance

THOMSON REUTERS
·
Jan 29

Jefferies Sticks to Its Buy Rating for Brookdale Senior Living (BKD)

TIPRANKS
·
Jan 27

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Boston Scientific (BSX) and Brookdale Senior Living (BKD)

TIPRANKS
·
Jan 26

Brookdale Senior Living Is Maintained at Overweight by Barclays

Dow Jones
·
Jan 23

Brookdale Senior Living (BKD) Gets a Buy from Jefferies

TIPRANKS
·
Jan 22

Brookdale Senior Living price target raised to $15 from $14 at Barclays

TIPRANKS
·
Jan 22